Page 24 - PPTL.QM.001 Iss 01 - ISO 9001 Quality Manual - Full [Unsigned]
P. 24

QUALITY MANUAL





                                                                            PHILLIPS PHARMACEUTICALS (TANZANIA) LIMITED



            DOCUMENT NUMBER                                        ISSUE NUMBER                                          SUPERSEDES                                   EFFECTIVE DATE

                  PPTL/QM/001                                                  02                                                 01                                      14.12.2018



           nature  of  the  nonconformity  and  its  effect  on  the  conformity  of  products  and  services.  This  shall  also  apply  to

           nonconforming products and services detected after delivery of products, during or after the provision of services.



           The organization shall deal with nonconforming outputs in one or more of the following ways:

                 •      Correction.

                 •      Segregation, containment, return or suspension of provision of products and services.

                 •      Informing the customer.

                 •      Obtaining authorization for acceptance under concession.

                 •      Conformity to the requirements shall be verified when nonconforming outputs are corrected.


           8.7.2 The organization shall retain documented information that:


                 •      Describes the nonconformity.

                 •      Describes the actions taken.

                 •      Describes the concessions obtained.

                 •      Identifies the authority deciding the action in respect of the nonconformity.


           A  documented  procedure,  Procedure  for  Control  for  Nonconforming  Outputs  –  Handling  Deviations

           PPTL/SOP/QA/006 is in place to ensure that product and service which does not conform to requirements is

           identified  and  controlled  to  prevent  its  unintended  use  or  delivery.  Non-conforming  product  and  service  is

           dealt with in one of the following ways:

                 •      By taking action to eliminate the detected nonconformity.

                 •      By taking action to preclude its original use or application.



           Records of the nature of nonconformities and any subsequent actions taken, including concessions obtained,

           are maintained. When non-conforming product is detected after collection, delivery, or use has started, Phillips

           Pharmaceuticals  (Tanzania)  Limited  takes  action  appropriate  to  the  effects,  or  potential  affects,  of  the

           nonconformity. Procedures for monitoring the effects of the products in the market is covered by a separate

           Quality manual altogether – PPTL/QM/002 – Pharmacovigilance Quality Manual.

























































                                                                                                                                                                      P a g e  23 | 28
   19   20   21   22   23   24   25   26   27   28   29